Annual Retained Earnings
$2.82 B
+$692.95 M+32.51%
December 31, 2023
Summary
- As of February 7, 2025, GMAB annual retained earnings is $2.82 billion, with the most recent change of +$692.95 million (+32.51%) on December 31, 2023.
- During the last 3 years, GMAB annual retained earnings has risen by +$1.65 billion (+140.44%).
- GMAB annual retained earnings is now at all-time high.
Performance
GMAB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
$2.94 B
+$336.14 M+12.91%
September 1, 2024
Summary
- As of February 7, 2025, GMAB quarterly retained earnings is $2.94 billion, with the most recent change of +$336.14 million (+12.91%) on September 1, 2024.
- Over the past year, GMAB quarterly retained earnings has increased by +$325.83 million (+12.47%).
- GMAB quarterly retained earnings is now at all-time high.
Performance
GMAB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
GMAB Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +32.5% | +12.5% |
3 y3 years | +140.4% | +36.9% |
5 y5 years | +9411.7% | +36.9% |
GMAB Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +85.2% | at high | +92.7% |
5 y | 5-year | at high | +784.5% | at high | +820.4% |
alltime | all time | at high | +384.8% | at high | +396.4% |
Genmab A/S Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.94 B(+12.9%) |
Jun 2024 | - | $2.60 B(-9.1%) |
Mar 2024 | - | $2.86 B(+1.4%) |
Dec 2023 | $2.82 B(+32.5%) | $2.82 B(+8.1%) |
Sep 2023 | - | $2.61 B(+10.8%) |
Jun 2023 | - | $2.36 B(+9.9%) |
Mar 2023 | - | $2.15 B(+0.7%) |
Dec 2022 | $2.13 B(+39.7%) | $2.13 B(+12.8%) |
Sep 2022 | - | $1.89 B(+10.0%) |
Jun 2022 | - | $1.72 B(+9.0%) |
Mar 2022 | - | $1.58 B(+3.4%) |
Dec 2021 | $1.53 B(+29.9%) | $1.53 B(+7.0%) |
Sep 2021 | - | $1.43 B(+9.1%) |
Jun 2021 | - | $1.31 B(+3.4%) |
Mar 2021 | - | $1.26 B(+7.6%) |
Dec 2020 | $1.17 B(+267.9%) | $1.17 B(+15.3%) |
Sep 2020 | - | $1.02 B(+14.8%) |
Jun 2020 | - | $887.33 M(+147.3%) |
Mar 2020 | - | $358.88 M(+12.4%) |
Dec 2019 | $319.33 M(-1152.8%) | $319.33 M(+256.5%) |
Sep 2019 | - | $89.57 M(+1736.4%) |
Jun 2019 | - | $4.88 M(-134.5%) |
Mar 2019 | - | -$14.13 M(-53.4%) |
Dec 2018 | -$30.33 M(-89.9%) | -$30.33 M(-82.7%) |
Sep 2018 | - | -$175.48 M(-15.1%) |
Jun 2018 | - | -$206.59 M(-22.9%) |
Mar 2018 | - | -$267.86 M(-10.4%) |
Dec 2017 | -$298.89 M(-32.3%) | -$298.89 M(-29.2%) |
Sep 2017 | - | -$422.03 M(+2.1%) |
Jun 2017 | - | -$413.43 M(-5.0%) |
Mar 2017 | - | -$435.23 M(-1.5%) |
Dec 2016 | -$441.72 M | -$441.72 M(-25.9%) |
Sep 2016 | - | -$596.34 M(-1.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2016 | - | -$605.02 M(-5.9%) |
Mar 2016 | - | -$642.80 M(+3.8%) |
Dec 2015 | -$619.36 M(-24.6%) | -$619.36 M(-11.3%) |
Sep 2015 | - | -$698.12 M(-2.8%) |
Jun 2015 | - | -$718.11 M(+3.2%) |
Mar 2015 | - | -$696.15 M(-15.2%) |
Dec 2014 | -$820.98 M(-17.2%) | -$820.98 M(-5.7%) |
Sep 2014 | - | -$870.15 M(-9.8%) |
Jun 2014 | - | -$964.37 M(-0.3%) |
Mar 2014 | - | -$967.06 M(-2.5%) |
Dec 2013 | -$991.60 M(+2.1%) | -$991.60 M(+1.1%) |
Sep 2013 | - | -$980.83 M(+3.4%) |
Jun 2013 | - | -$948.57 M(+2.1%) |
Mar 2013 | - | -$929.09 M(-4.4%) |
Dec 2012 | -$971.51 M(+11.4%) | -$971.51 M(+9.5%) |
Sep 2012 | - | -$887.20 M(+4.6%) |
Jun 2012 | - | -$848.58 M(-6.5%) |
Mar 2012 | - | -$907.55 M(+4.0%) |
Dec 2011 | -$872.38 M(+10.4%) | -$872.38 M(-3.8%) |
Sep 2011 | - | -$906.41 M(+1.3%) |
Jun 2011 | - | -$894.42 M(+4.2%) |
Mar 2011 | - | -$858.45 M(+8.6%) |
Dec 2010 | -$790.24 M(-1.6%) | -$790.24 M(-0.8%) |
Sep 2010 | - | -$796.32 M(+11.6%) |
Jun 2010 | - | -$713.47 M(-8.3%) |
Mar 2010 | - | -$778.07 M(-3.1%) |
Dec 2009 | -$802.99 M(+29.1%) | -$802.99 M |
Dec 2008 | -$622.21 M(+27.0%) | - |
Dec 2007 | -$490.04 M(+25.2%) | - |
Dec 2006 | -$391.48 M(+33.6%) | - |
Dec 2005 | -$293.09 M(+11.4%) | - |
Dec 2004 | -$262.98 M(+51.0%) | - |
Dec 2003 | -$174.10 M(+75.6%) | - |
Dec 2002 | -$99.14 M | - |
FAQ
- What is Genmab A/S annual retained earnings?
- What is the all time high annual retained earnings for Genmab A/S?
- What is Genmab A/S annual retained earnings year-on-year change?
- What is Genmab A/S quarterly retained earnings?
- What is the all time high quarterly retained earnings for Genmab A/S?
- What is Genmab A/S quarterly retained earnings year-on-year change?
What is Genmab A/S annual retained earnings?
The current annual retained earnings of GMAB is $2.82 B
What is the all time high annual retained earnings for Genmab A/S?
Genmab A/S all-time high annual retained earnings is $2.82 B
What is Genmab A/S annual retained earnings year-on-year change?
Over the past year, GMAB annual retained earnings has changed by +$692.95 M (+32.51%)
What is Genmab A/S quarterly retained earnings?
The current quarterly retained earnings of GMAB is $2.94 B
What is the all time high quarterly retained earnings for Genmab A/S?
Genmab A/S all-time high quarterly retained earnings is $2.94 B
What is Genmab A/S quarterly retained earnings year-on-year change?
Over the past year, GMAB quarterly retained earnings has changed by +$325.83 M (+12.47%)